PMID- 35221612 OWN - NLM STAT- MEDLINE DCOM- 20220301 LR - 20220502 IS - 2413-7170 (Electronic) IS - 1029-1857 (Print) IS - 1029-1857 (Linking) VI - 31 IP - 5 DP - 2021 Sep TI - Clinical Presentation of Retinoblastoma in Ethiopia: A Case of Jimma University Medical Center Pediatric Oncology Unit, Southwest Ethiopia. PG - 963-968 LID - 10.4314/ejhs.v31i5.7 [doi] AB - BACKGROUND: Retinoblastoma (RB) is one of the most curable childhood cancers if early detected and treated. Late presentation complicates the management of RB results in dismal treatment outcome. Objective: The aim of this study is to report the clinical presentation pattern of retinoblastoma patients seen at Jimma University Medical center (JUMC). METHODS: The study was a retrospective review of retinoblastoma cases managed at JUMC between August 2016 and July 2020. RESULTS: Among pediatric oncology cases registered retinoblastoma, accounting 8.5 % (36/423) of all childhood cancer patients in the study period, 29 (90.6%) of them had unilateral retinoblastoma and 3(9.4%) of them had bilateral retinoblastoma. The average age at presentation for bilateral and unilateral retinoblastoma patients was 17 (range 3-30) months and 37.5 months (range 8-84) respectively. The first symptom observed by the family was leukocoria in 21 (65.6%) of the patients but 24(75%) of the patients presented with advanced stage (proptosis and fungating orbital mass) of the disease. The longest and the shortest lag time of presentation from the first symptom was 17 months and 2 weeks respectively with the mean lag time of 1.4 months in bilateral and 6 months in unilateral cases. Clinically, the majority of the eyes 24/35(68.6%) were extraocular tumors involving orbital tissues at presentation. CONCLUSION: Most of retinoblastoma patients presented at advanced stage of the disease and presented very late after the family observed the disease. Early detection strategies must be designed by the government and responsible stakeholders in mitigating the effects of late presentation. CI - (c) 2021 Diriba Fufa Hordofa, et al. FAU - Hordofa, Diriba Fufa AU - Hordofa DF AD - Jimma University, Departement of Pediatrics, Jimma, Ethiopia. FAU - Daba, Kumale Tolesa AU - Daba KT AD - Jimma University Departement of ophthalmology. Jimma, Ethiopia. FAU - Mengesha, Aemero Abateneh AU - Mengesha AA AD - Bahir Dar University Departement of Ophthalmology, Bahir Dar, Ethiopia. LA - eng PT - Case Reports PT - Journal Article PL - Ethiopia TA - Ethiop J Health Sci JT - Ethiopian journal of health sciences JID - 101224773 SB - IM MH - Academic Medical Centers MH - Child MH - Child, Preschool MH - Ethiopia/epidemiology MH - Eye/pathology MH - Humans MH - Infant MH - *Retinal Neoplasms/diagnosis/epidemiology/therapy MH - *Retinoblastoma/diagnosis/epidemiology/therapy MH - Retrospective Studies PMC - PMC8843152 OTO - NOTNLM OT - Retinoblastoma OT - leukocoria OT - orbital disease EDAT- 2022/03/01 06:00 MHDA- 2022/03/03 06:00 PMCR- 2021/09/01 CRDT- 2022/02/28 05:31 PHST- 2021/05/21 00:00 [received] PHST- 2021/05/26 00:00 [accepted] PHST- 2022/02/28 05:31 [entrez] PHST- 2022/03/01 06:00 [pubmed] PHST- 2022/03/03 06:00 [medline] PHST- 2021/09/01 00:00 [pmc-release] AID - jEJHS.v31.i5.pg963 [pii] AID - 10.4314/ejhs.v31i5.7 [doi] PST - ppublish SO - Ethiop J Health Sci. 2021 Sep;31(5):963-968. doi: 10.4314/ejhs.v31i5.7.